Extracorporeal circulation, optimized: a pilot study

Area of Science:

• Cardiovascular Surgery
• Biomaterials Science
• Medical Device Technology

Background:

• Cardiopulmonary bypass (CPB) systems are crucial in cardiac surgery but can trigger inflammatory responses and blood product usage.
• Optimizing CPB circuits is essential for improving patient outcomes and reducing complications.
• Existing CPB technologies have limitations in biocompatibility and inflammatory modulation.

Purpose of the Study:

• To evaluate the safety and efficacy of a novel phosphorylcholine-coated, closed CPB system (ECC.O).
• To compare the ECC.O system's performance against conventional non-phosphorylcholine-bonded circuits and off-pump coronary artery bypass (OPCAB).

Main Methods:

• A pilot study involving 30 patients undergoing first-time coronary artery bypass grafting (CABG) using the ECC.O system (Group I).
• Retrospective comparison with 32 patients using non-phosphorylcholine-bonded circuits (Group II) and 26 patients undergoing OPCAB (Group III).
• Assessment of hematocrit levels, red blood cell transfusion rates, and C-reactive protein (CRP) levels post-surgery.

Main Results:

• Group I demonstrated significantly higher initial hematocrit levels post-CPB compared to Group II (29.7% vs. 22.7%, P < 0.001).
• The ECC.O system drastically reduced the red blood cell transfusion rate in Group I versus Group II (P < 0.001).
• Significantly lower C-reactive protein levels were observed at 24 hours and 72 hours in Group I compared to both Group II and Group III (P < 0.001).

Conclusions:

• The ECC.O system is clinically safe and efficacious for CPB.
• The phosphorylcholine coating appears to mitigate inflammatory responses and reduce the need for blood transfusions.
• Implementation requires comprehensive training for surgical and perfusion teams.